[ET Net News Agency, 15 September 2021] SINO BIOPHARM (01177) fell 3.15% to HK$6.46,
dipping below the 20-D SMA of HK$6.556.
It hits an intra-day low of HK$6.46, and an intra-day high of HK$6.71. The total shares
traded was 25.11 million, with a value of HK$164.65m. The active buy/sell ratio is 48:52,
with net selling turnover of HK$7.09m. CHINA INV INFO accounts for greatest net responsive
buying turnover of HK$7.36m, with volume weighted average price of HK$6.542. J.P. MORGAN
BRO (HK) accounts for greatest net responsive selling turnover of HK$12.85m, with volume
weighted average price of HK$6.559. The stock has fallen a combined 4.58% over the past 3
consecutive trading days.
The Hang Seng Index now fell 424 points, or 1.66% to 25,077; the Hang Seng China
Enterprises Index now fell 128 points, or 1.41% to 8,953; the Hang Seng TECH Index now
fell 165 points, or 2.55% to 6,336; with an overall turnover of HK$93.31b.
The SSE Composite Index now fell 14 points, or 0.41% to 3,647, with an overall turnover
of RMB441.03b.
The SZSE Component Index now fell 122 points, or 0.84% to 14,503, with an overall
turnover of RMB252.26b.

Basic Information
-------------------------------------------
Nominal 6.460 % Chg -3.15%
High 6.710 Low 6.460
Shares Tr 25.11m Turnover 164.65m
10-D SMA 6.701 %H.V 31.913
20-D SMA 6.556 VWAP 6.557
50-D SMA 6.714 RSI14 42.830
-------------------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 48:52, with net selling
turnover of HK$7.09m, falling a combined 4.58% over the past 3 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SINO BIOPHARM (01177) 6.46 -3.15
SIHUAN PHARM (00460) 2.08 -2.35
TRAD CHI MED (00570) 3.60 -4.26
CMS (00867) 14.66 -2.27
CSPC PHARMA (01093) 9.57 -1.34
3SBIO (01530) 8.27 -3.73
FOSUN PHARMA (02196) 46.10 -4.26
WUXI APPTEC (02359) 169.60 +0.41
HANSOH PHARMA (03692) 20.05 -4.07
PHARMARON (03759) 182.20 -1.19
-------------------------------------------------
(ed)